-
公开(公告)号:US07713937B2
公开(公告)日:2010-05-11
申请号:US12119311
申请日:2008-05-12
申请人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
IPC分类号: A61K38/07
CPC分类号: C07K5/1016 , C07K7/02
摘要: The invention relates to synthetic peptide amides that are ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: wherein Xaa is a D-amino acid and G is selected from the following three groups: The compounds are useful in the prophylaxis and treatment of pain, pruritis and inflammation associated with a variety of diseases and conditions.
摘要翻译: 本发明涉及作为κ阿片受体的配体的合成肽酰胺,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片样物质受体的激动剂。 本发明的合成肽酰胺符合以下结构:其中Xaa是D-氨基酸,G选自以下三组:所述化合物可用于预防和治疗与各种各样的相关的疼痛,瘙痒和炎症 疾病和病症。
-
公开(公告)号:US20100029575A1
公开(公告)日:2010-02-04
申请号:US12300610
申请日:2007-05-25
申请人: Jean-Louis Junien , Pierre J.M. Riviere , Claudio D. Schteingart , Javier Sueiras Diaz , Jerzy A. Trojnar , Todd W. Vanderah , Michael E. Lewis
发明人: Jean-Louis Junien , Pierre J.M. Riviere , Claudio D. Schteingart , Javier Sueiras Diaz , Jerzy A. Trojnar , Todd W. Vanderah , Michael E. Lewis
CPC分类号: C07K5/1016 , A61K38/00
摘要: Certain peptides which exhibit high selectivity for the kappa opioid receptor (KOR) versus the mu opioid receptor and little or no CYP3A4 inhibitory activity including tetrapeptides of four D-isomer amino acid residues having a C-terminus which is an N-oxide-substituted amide such, as H-D-Phe-D-Phe-D-Nle-D-Arg-NH-4-picolyl-N-oxide. A preferred compound, which has an affinity for the KOR at least 1,000 times its affinity for the mu opioid receptor and an IC50 for CYP3 A4 of greater than about 10 micromolar, is H-D-Phe-D-Phe-D-Nle-D-Arg-NH-4-picolyl-N-oxide
摘要翻译: 对于κ阿片样物质受体(KOR)与μ-阿片样物质受体显示出高选择性的某些肽,并且很少或没有CYP3A4抑制活性,包括具有C-末端的四个D-异构体氨基酸残基的四肽,其是N-氧化物取代的酰胺 如HD-Phe-D-Phe-D-Nle-D-Arg-NH-4-吡啶甲酰基-N-氧化物。 HD-Phe-D-Phe-D-Nle-D-D对于KOR具有对μ-阿片样物质受体的亲和力至少1000倍的亲和力以及大于约10微摩尔的CYP3A4的IC 50的优选化合物, Arg-NH-4-吡啶甲酰基-N-氧化物
-
公开(公告)号:US20090156508A1
公开(公告)日:2009-06-18
申请号:US12119311
申请日:2008-05-12
申请人: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
CPC分类号: C07K5/1016 , C07K7/02
摘要: The invention relates to synthetic peptide amides that are ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: wherein Xaa is a D-amino acid and G is selected from the following three groups: The compounds are useful in the prophylaxis and treatment of pain, pruritis and inflammation associated with a variety of diseases and conditions.
摘要翻译: 本发明涉及作为κ阿片受体的配体的合成肽酰胺,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片样物质受体的激动剂。 本发明的合成肽酰胺符合以下结构:其中Xaa是D-氨基酸,G选自以下三组:所述化合物可用于预防和治疗与各种各样的相关的疼痛,瘙痒和炎症 疾病和病症。
-
公开(公告)号:US20130012448A1
公开(公告)日:2013-01-10
申请号:US13543022
申请日:2012-07-06
申请人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
CPC分类号: C07K5/1016 , A61K38/00 , A61K38/07 , C07K5/10 , C07K5/1008 , C07K5/101 , C07K7/02
摘要: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure of formula I: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.
-
公开(公告)号:US20090075907A1
公开(公告)日:2009-03-19
申请号:US12176279
申请日:2008-07-18
申请人: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
CPC分类号: C07K5/1016 , A61K38/00 , A61K38/07 , C07K5/10 , C07K5/1008 , C07K5/101 , C07K7/02
摘要: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure of formula I: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.
摘要翻译: 本发明涉及κ阿片样物质受体的合成肽酰胺配体,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片受体激动剂。 本发明的合成肽酰胺符合式I的结构:含有这些化合物的药物组合物可用于预防和治疗与多种疾病和病症相关的疼痛和炎症。 这种可治疗的疼痛包括内脏痛,神经性疼痛和痛觉过敏。 与IBD和IBS等条件相关的炎症,眼部和耳部炎症,其他疾病和病症如瘙痒症,水肿,低钠血症,低钾血症,肠梗阻,肠炎和青光眼均可用本发明的药物组合物治疗或预防。
-
公开(公告)号:US08951970B2
公开(公告)日:2015-02-10
申请号:US13543022
申请日:2012-07-06
申请人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
CPC分类号: C07K5/1016 , A61K38/00 , A61K38/07 , C07K5/10 , C07K5/1008 , C07K5/101 , C07K7/02
摘要: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure of formula I: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.
摘要翻译: 本发明涉及κ阿片样物质受体的合成肽酰胺配体,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片受体激动剂。 本发明的合成肽酰胺符合式I的结构:含有这些化合物的药物组合物可用于预防和治疗与多种疾病和病症相关的疼痛和炎症。 这种可治疗的疼痛包括内脏痛,神经性疼痛和痛觉过敏。 与IBD和IBS等条件相关的炎症,眼部和耳部炎症,其他疾病和病症如瘙痒症,水肿,低钠血症,低钾血症,肠梗阻,肠炎和青光眼均可用本发明的药物组合物治疗或预防。
-
公开(公告)号:US20120231999A1
公开(公告)日:2012-09-13
申请号:US13503010
申请日:2010-10-21
申请人: Sudarkodi Alagarsamy , Guangcheng Jiang , Pierre Riviere , Claudio Daniel Schteingart , Javier Sueiras-Diaz
发明人: Sudarkodi Alagarsamy , Guangcheng Jiang , Pierre Riviere , Claudio Daniel Schteingart , Javier Sueiras-Diaz
IPC分类号: A61K38/16 , A61P1/00 , A61P3/04 , A61P3/10 , A61P1/04 , A61P37/08 , A61P29/00 , A61P25/24 , A61P19/10 , A61P25/00 , C07K14/00 , A61P3/00
CPC分类号: C07K14/605 , A61K38/00
摘要: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.
摘要翻译: 描述了具有改善的药代动力学性质的新型GLP-2类似物以及它们在治疗疾病中的用途。
-
公开(公告)号:US07842662B2
公开(公告)日:2010-11-30
申请号:US11938776
申请日:2007-11-12
申请人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frédérique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
IPC分类号: A61K38/00
CPC分类号: C07K5/1016 , A61K38/00 , C07K5/1005 , C07K5/1008 , C07K5/1024 , C07K7/06
摘要: The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.
摘要翻译: 本发明涉及κ阿片样物质受体的合成肽酰胺配体,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片受体激动剂。 本发明的合成肽酰胺符合以下结构:含有这些化合物的药物组合物可用于预防和治疗与各种疾病和病症相关的疼痛和炎症。 这种可治疗的疼痛包括内脏痛,神经性疼痛和痛觉过敏。 与IBD和IBS等条件相关的炎症,眼部和耳部炎症,其他疾病和病症如瘙痒症,水肿,低钠血症,低钾血症,肠梗阻,肠炎和青光眼均可用本发明的药物组合物治疗或预防。
-
公开(公告)号:US07727963B2
公开(公告)日:2010-06-01
申请号:US12176279
申请日:2008-07-18
申请人: Claudio D. Schteingart , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Zhiyong Luo
发明人: Claudio D. Schteingart , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Zhiyong Luo
IPC分类号: A61K38/07
CPC分类号: C07K5/1016 , A61K38/00 , A61K38/07 , C07K5/10 , C07K5/1008 , C07K5/101 , C07K7/02
摘要: The invention relates to synthetic tetrapeptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. An exemplary synthetic tetrapeptide amide of the invention is D-Phe-D-Phe-D-Leu-(ε-Me) D-Lys-[4-Amidinohomopiperazine amide]: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.
摘要翻译: 本发明涉及κ阿片样物质受体的合成四肽酰胺配体,特别涉及表现出低P450 CYP抑制和低渗透入脑的κ阿片受体激动剂。 本发明的示例性合成四肽酰胺是D-Phe-D-Phe-D-Leu-(α-Me)D-Lys- [4-脒基高密度哌嗪酰胺]:含有这些化合物的药物组合物可用于预防和治疗 与各种疾病和病症相关的疼痛和炎症。 这种可治疗的疼痛包括内脏痛,神经性疼痛和痛觉过敏。 与IBD和IBS等条件相关的炎症,眼部和耳部炎症,其他疾病和病症如瘙痒症,水肿,低钠血症,低钾血症,肠梗阻,肠炎和青光眼均可用本发明的药物组合物治疗或预防。
-
公开(公告)号:US20100075910A1
公开(公告)日:2010-03-25
申请号:US12480059
申请日:2009-06-08
申请人: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
发明人: Claudio D. Schteingart , Frederique Menzaghi , Guangcheng Jiang , Roberta Vezza Alexander , Javier Sueiras-Diaz , Robert H. Spencer , Derek T. Chalmers , Zhiyong Luo
CPC分类号: C07K5/1016 , C07K7/02
摘要: The invention relates to synthetic peptide amides that are ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: wherein Xaa is a D-amino acid and G is selected from the following three groups: The compounds are useful in the prophylaxis and treatment of pain, pruritus and inflammation associated with a variety of diseases and conditions.
摘要翻译: 本发明涉及作为κ阿片受体的配体的合成肽酰胺,特别是涉及低P450 CYP抑制和低渗透入脑的κ阿片样物质受体的激动剂。 本发明的合成肽酰胺符合以下结构:其中Xaa是D-氨基酸,G选自以下三组:所述化合物可用于预防和治疗与各种各样的相关的疼痛,瘙痒和炎症 疾病和病症。
-
-
-
-
-
-
-
-
-